inactivated-adjuvanted SARS-CoV-2 virus vaccine
Showing 9976 - 10000 of >10,000
Covid-19 in Chronic Inflammatory Rheumatism, Auto-immune or
Unknown status
- Sars-CoV2
- +2 more
-
Lille, FranceHôpital Huriez
Apr 21, 2020
Virtual Reality Trial (Immersive 360 (3D) video)
Not yet recruiting
- Virtual Reality
- Immersive 360 (3D) video
- (no location specified)
May 30, 2023
Type 1 Diabetes Trial in Kuwait City (Morning exercise, Afternoon exercise, Habitual physical activity levels)
Not yet recruiting
- Type 1 Diabetes
- Morning exercise
- +2 more
-
Kuwait City, KuwaitDasman Diabetes Institute
May 22, 2023
Using Surplus qFIT Samples to Investigate the Gut Microbiota.
Not yet recruiting
- Gut Microbiota
- No intervention
-
Aberdeen, United KingdomRowett Institute
Oct 17, 2023
Advanced Malignant Solid Tumor Trial in Huntersville (BNT314, Pembrolizumab)
Not yet recruiting
- Advanced Malignant Solid Tumor
- BNT314
- Pembrolizumab
-
Huntersville, North CarolinaCarolina BioOncology Institute, LLC
Nov 21, 2023
Physical Activity Trial in Singapore (Hedonic Reward, Cash Reward, Fitbit)
Recruiting
- Physical Activity
- Hedonic Reward
- +2 more
-
Singapore, SingaporeDuke-NUS Medical School
Jan 12, 2023
Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Mitoxantrone Hydrochloride Liposome Injection
- (no location specified)
Sep 20, 2022
Autism Spectrum Disorder Trial in Lahore (SPARK)
Completed
- Autism Spectrum Disorder
- SPARK
-
Lahore, Punjab, PakistanRiphah Rehabilitation Center
Aug 8, 2023
Aromatherapy by Olfaction of Essential Oils in Association With
Not yet recruiting
- Cancer
- hypnosis
- Hypnosis with aromatherapy
-
Créteil, FranceCentre Hospitalier Intercommunal de Créteil
Feb 3, 2023
Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia Trial in Japan (Blinatumomab)
Completed
- Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia
-
Nagoya-shi, Aichi, Japan
- +15 more
Dec 8, 2022
NSCLC Trial (TAS3351 oral administration)
Not yet recruiting
- Non-Small Cell Lung Cancer
- TAS3351 oral administration
- (no location specified)
Mar 8, 2023
IBD Trial in San Diego (Electronic medical record portal videos, General adolescent health videos)
Active, not recruiting
- Inflammatory Bowel Diseases
- Electronic medical record portal videos
- General adolescent health videos
-
San Diego, CaliforniaRady Children's Hospital
Oct 20, 2023
Double-fortified Salt Containing Iodine and Folic Acid - Phase 1
Not yet recruiting
- Folate Deficiency
- +4 more
-
Addis Ababa, EthiopiaEthiopian Public Health Institute
Mar 30, 2023
E-cigarette Use, Tobacco Use Cessation Trial in Milwaukee (Computerized attentional bias modification training, Placebo
Recruiting
- E-cigarette Use
- Tobacco Use Cessation
- Computerized attentional bias modification training
- Placebo attention control training
-
Milwaukee, WisconsinUniversity of Wisconsin-Milwaukee
Nov 1, 2022
PTSD, MDD Trial in Newark, Cleveland, Seattle (Positive Processes and Transition to Health, Progressive Muscle Relaxation)
Not yet recruiting
- Posttraumatic Stress Disorder
- Major Depressive Disorder
- Positive Processes and Transition to Health
- Progressive Muscle Relaxation
-
Newark, Delaware
- +2 more
Oct 17, 2023
Carnitine Deficiency Due to Hemodialysis Trial in Cairo (L-carnitine, isotonic saline)
Recruiting
- Carnitine Deficiency Due to Hemodialysis
- L-carnitine
- isotonic saline
-
Cairo, EgyptAin Shams university
Jul 13, 2023
Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)
Not yet recruiting
- Stage III NSCLC
- Surgery
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Feb 21, 2023
Cancer, Heart Failure, Arrhythmia Trial in Harbin (Control group:DH001 , Trial group: DH001 low-dose group, Trial group: DH001
Recruiting
- Cancer
- +4 more
- Control group:DH001 placebo
- +2 more
-
Harbin, Heilongjiang, ChinaHarbin Institute of Hematology and Cancer
Oct 20, 2023
High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)
Not yet recruiting
- High-Risk de Novo Multiple Myeloma
- Daratumumab
- +5 more
-
Badalona, Spain
- +9 more
Apr 27, 2023
ROTEM and Platelet Indices in Thrombocytopenic Patients .
Not yet recruiting
- Patients With Low Platelets Counts
- (no location specified)
Apr 29, 2023
Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Histamine Dihydrochloride (HDC)
- Interleukin-2 (IL-2)
- (no location specified)
Mar 31, 2023